×
ADVERTISEMENT

metabolic dysfunction–associated steatotic liver disease

Low-Dose Aspirin Reduces Liver Fat in Patients With MASLD in Phase 2 Trial

A daily dose of aspirin led to a significant reduction in liver fat in patients with metabolic ...

AUGUST 2, 2024

Load more